A number of candidate genes for lithium prophylactic efficacy have been proposed, some of them being also associated with a predisposition to bipolar illness. The aim of the present study was to investigate a possible association between polymorphisms of 14 common genes with the quality of prophylactic lithium response in patients with bipolar mood disorder, in relation to the putative role of these genes in the pathogenesis of this disorder. Some association with lithium prophylactic efficacy was found for the polymorphisms of 5HTT, DRD1, COMT, BDNF and FYN genes, but not for 5HT2A, 5HT2C, DRD2, DRD3, DRD4, GSK-3, NTRK2, GRIN2B and MMP-9. Possible aspects of these genes with regard to the mechanism of lithium activity and pathogenesis of bipolar mood disorder are discussed.
ArinamiTGaoMHamaguchiHToruM (1997) A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum Mol Genet6: 577–582.
2.
BALANCE investigators and collaborators, GeddesJRGoodwinGMRendellJAzorinJMCiprianiA. (2010) Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomized open-label trial. Lancet375: 385–395.
3.
CichonSNothenMMErdmannJProppingP (1994) Detection of four polymorphic sites in the human dopamine D1 receptor gene (DRD1). Hum Mol Genet3: 209.
4.
Dmitrzak-WeglarzMRybakowskiJKSlopienACzerskiPMLeszczynska-RodziewiczAKapelskiP. (2006) Dopamine receptor D1 gene -48A/G polymorphism is associated with bipolar illness but not with schizophrenia in a Polish population. Neuropsychobiology53: 51–56.
5.
Dmitrzak-WeglarzMRybakowskiJKSuwalskaASkibinskaMLeszczynska-RodziewiczASzczepankiewiczA. (2008) Association studie of the BDNF and the NTRK2 gene polymorphisms with prophylactic lithium response in bipolar patients. Pharmacogenomics9: 1595–1603.
6.
DragoADe RonchiDSerrettiA (2009) Pharmacogenetics of antidepressant response: an update. Hum Genomics3: 257–274.
7.
DuLBakishDLapierreYDRavindranAVHrdinaPD (2000) Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder. Am J Med Genet96: 56–60.
8.
FirstMBSpitzerRLGibbonMWilliamsJ (1996) Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). Washington, DC: American Psychiatric Press.
9.
FukumotoTMorinobuSOkamotoYKagayaAYamawakiS (2001) Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology158: 100–106.
10.
GeddesJRBurgessSKawtonKJamisonKGoodwinGM (2004) Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry161: 217–222.
11.
GreenEKRaybouldRMacgregorSHydeSYoungAHO’DonovanMC. (2006) Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar disorder: case-control study of over 3000 individuals from the UK. Br J Psychiatry188: 21–25.
12.
GrofP (1999) Excellent lithium responders: people whose lives have been changed by lithium prophylaxis. In: BirchNJGallicchioVSBeckerRW (eds) Lithium: 50 Years of Psychopharmacology, New Perspectives in Biomedical and Clinical Research, Cheshire, Connecticut: Weidner Publishing Group, 36–51.
13.
HartiganG (1963) The use of lithium salts in affective disorders. Br J Psychiatry109: 810–814.
14.
HauserJLeszczynskaASamochowiecJCzerskiPMOstapowiczAChlopockaM. (2003) Association analysis of the insertion/deletion polymorphism in serotonin transporter gene in patients with affective disorder. Eur Psychiatry18: 129–132.
15.
IshiguroHSaitoTShibuyaHToruMArinamiT (2000) Mutation and association analysis of the FYN kinase gene with alcoholism and schizophrenia. Am J Med Genet96: 716–720.
16.
JönssonEGIvoRForslundKMattila-EvendenMRylanderGCichonS. (2001) No association between a promoter dopamine D(4) receptor gene variant and schizophrenia. Am J Med Genet105: 525–528.
17.
KunugiHUekiAOtsukaMIsseKHirasawaHKatoN. (2001) A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer’s disease. Mol Psychiatry6: 83–86.
18.
LannfeltLSokoloffPMartresMPilonCGirosBJonssonE. (1992) Amino-acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders. Psychiatr Genet2: 249–256.
19.
LappalainenJZhangLDeanMOzMOzakiNYuDH. (1995) Identification, expression, and pharmacology of a Cys23-Ser23 substitution in the human 5-HT2c receptor gene (HTR2C). Genomics27: 274–279.
20.
LiTVallladaHCurtisDArranzMXuKCaiG. (1997) Catechol-O-methyltransferase Val158Met polymorphism: frequency analysis in Han Chinese subjects and allelic association of the low activity allele with bipolar affective disorder. Pharmacogenetics7: 349–353.
21.
MullerDJdeLucaVSicardTKingNStraussJKennedyJL (2006) Brain-derived neurotrophic factor gene and rapid-cycling bipolar disorders: family-based association study. Br J Psychiatry189: 317–323.
22.
NevesFSSilveiraGRomano-SilvaMAMalloy-DinizLFerreiraAADeMarcoL. (2008) Is the 5-HTTLPR polymorphism associated with bipolar disorder or with suicidal behavior of bipolar disorder patients?Am J Med Genet147B: 114–116.
23.
Neves-PereiraMMundoEMugliaPKingNMacciardiFKennedyJL (2002) The brain-derived neurotropic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet71: 651–655.
24.
NivoliAMAMurruAVietaE (2010) Lithium: still a cornerstone in the long-term treatment in bipolar disorder?Neuropsychobiology62: 27–35.
25.
OhtsukiTSakuraiKDouHToruMYamakawa-KobayashiKArinamiT (2001) Mutation analysis of the NMDAR2B (GRIN2B) gene in schizophrenia. Mol Psychiatry6: 211–216.
26.
RussCLovestoneSPowellJF (2001) Identification of sequence variants and analysis of the role of the glycogen synthase kinase 3 beta gene and promoter in late-onset Alzheimer’s disease. Mol Psychiatry6: 320–324.
27.
RybakowskiJKChłopocka-WoźniakMSuwalskaA (2001) The prophylactic effect of long-term lithium administration in bipolar patients entering lithium treatment in the 1970s and 1980s. Bipolar Disord3: 63–67.
RybakowskiJKSuwalskaASkibinskaMSzczepankiewiczALeszczynska-RodziewiczAPermodaA. (2005) Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene. Pharmacopsychiatry38: 166–170.
30.
SerrettiALilliRMandelliLLorenziCSmeraldiE (2001) Serotonin transporter gene associated with lithium prophylaxis in mood disorders. Pharmacogenomics J1: 71–77.
31.
SeverinoGCongiuDSerelliCDe LisaRChillottiCDel ZompoM. (2005) A48G polymorphism in the D1 receptor genes associated with bipolar I disorder. Am J Med Genet134B: 37–38.
32.
ShaldubinaAAganGBelmakerRH (2001) The mechanism of lithium action: state of the art, ten years later. Prog Neuropsychopharmacol Biol Psychiatry25: 855–866.
33.
SklarPGabrielSBMcInnisMGBennettPLimYMTsanG. (2002) Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Mol Psychiatry7: 579–593.
34.
StoltenbergSFTwitchellGRHannaGLCookEHFitzgeraldHEZuckerRA. (2002) Serotonin transporter promoter polymorphism, peripheral indexes of serotonin function, and personality measures in families with alcoholism. Am J Med Genet114: 230–234.
35.
SzczepankiewiczARybakowskiJKSkibinskaMDmitrzak-WeglarzMLeszczynska-RodziewiczAWilkoscM. (2009) FYN kinase gene: another glutamatergic gene associated with bipolar disorder?Neuropsychobiology59: 178–183.
36.
SzczepankiewiczARybakowskiJKSuwalskaASkibinskaMLeszczynska-RodziewiczADmitrzak-WeglarzM. (2006) Association study of the glycogen synthase kinase-3beta gene polymorphism with prophylactic lithium response in bipolar patients. World J Biol Psychiatry7: 158–161.
37.
TureckiGGrofPGrofED’SouzaVLebuisLMarineauC. (2001) Mapping susceptibility genes for bipolar disorder: a pharmacogenetic approach based on excellent response to lithium. Mol Psychiatry6: 570–578.
38.
VepsäläinenSCastrenEHelisalmiSIivonenSMannermaaALehtovirtaM. (2005) Genetic analysis of BDNF and TrkB gene polymorphisms in Alzheimer’s disease. J Neurol252: 423–428.
39.
WatanabeYMuratakeTKanekoNNunokawaASomeyaT (2006) No association between the brain-derived neurotrophic factor gene and schizophrenia in a Japanese population. Schizophr Res84: 29–35.
40.
ZhangBHenneyAErikssonPHamstenAWatkinsHYeS (1999) Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1. Hum Genet105: 418–423.
41.
ZhangZLindpaintnerKCheRHeZWangPFengG. (2009) The Val/met functional polymorphism in COMT confers susceptibility to bipolar disorder: evidence from an association study and a meta-analysis. J Neural Transm116: 1193–1200.
